Thomas Jefferson University, Investigative Drug Service — Philadelphia, Pennsylvania

Thomas Jefferson University, Investigative Drug Service is a clinical research site located in Philadelphia, Pennsylvania, United States 19107.

Crixeo Health Trust Score: 41/100 (POOR). This profile has not yet been claimed by the site owner.

Thomas Jefferson University, Investigative Drug Service has participated in 1 clinical trials.

Therapeutic areas: CD33 Positive Acute Myelogenous Leukemia.

Sponsors: Pfizer.

Sponsor Feasibility Report

Trust Score: 41/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Thomas Jefferson University, Investigative Drug Service?

Thomas Jefferson University, Investigative Drug Service has a Crixeo Trust Score of 41/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Thomas Jefferson University, Investigative Drug Service conducted?

Thomas Jefferson University, Investigative Drug Service has 1 clinical trials on record. Their work covers CD33 Positive Acute Myelogenous Leukemia.

Is Thomas Jefferson University, Investigative Drug Service accredited by Crixeo Health?

Thomas Jefferson University, Investigative Drug Service has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Thomas Jefferson University, Investigative Drug Service?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.